Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 141732-76-5
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
CAS NO:: |
141732-76-5 |
Appearance:: |
White Powder |
Molecular Formula:: |
C186H286N50O62S |
Molecular Weight:: |
4246.62000 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD08704781 |
CAS NO:: |
141732-76-5 |
Appearance:: |
White Powder |
Molecular Formula:: |
C186H286N50O62S |
Molecular Weight:: |
4246.62000 |
EINECS NO:: |
NA |
MDL NO:: |
MFCD08704781 |
Product Description:
Product Name: Exenatide acetate CAS NO: 141732-76-5
Synonyms:
EXENATIDE ACETATE(EXENDIN-4);
EXENATIDE ACETATE;
Chemical & Physical Properties:
Appearance: White powder
Assay :≥99.00%
Melting Point: >209℃ (dec.)
Storage: Refrigerator, under inert atmosphere
Solubility: Acetonitrile (Slightly), Water (Slightly)
Exenatide (i, INN, marketed as Byetta, Bydureon) is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2. Exenatide in its Byetta form is administered as a subcutaneous injection (under the skin) of the abdomen, thigh, or arm, any time within the 60 minutes before the first and last meal of the day. A once-weekly injection has been approved as of January 27, 2012 under the trademark Bydureon. It is manufactured by Amylin Pharmaceuticals and commercialized by AstraZeneca.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
